Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting
Titel:
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting
Auteur:
Mhibik, Maissa Gaglione, Erika M. Eik, David Herrick, John Le, Janet Ahn, Inhye E. Chiu, Christopher Wielgos-Bonvallet, Monica Hiemstra, Ida H. Breij, Esther C. W. Chen, Jenny Reilly, Edward B. Epling-Burnette, Pearlie K. Szafer-Glusman, Edith Sun, Clare Wiestner, Adrian